Livazo 2mg Uses

How old is patient?
sponsored

What is Livazo 2mg?

Livazo 2mg (Livazo 2mg) belongs to a group of drugs called HMG CoA reductase inhibitors, or "statins." Livazo 2mg reduces levels of "bad" cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood, while increasing levels of "good" cholesterol (high-density lipoprotein, or HDL).

Livazo 2mg is used to treat high cholesterol in adults. Lowering your cholesterol may help prevent heart disease and hardening of the arteries, conditions that can lead to heart attack, stroke, and vascular disease.

Livazo 2mg may also be used for purposes not listed in this medication guide.

Livazo 2mg indications

sponsored

Drug therapy should be one component of multiple-risk-factor intervention in individuals who require modifications of their lipid profile. Lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol only when the response to diet and other nonpharmacological measures has been inadequate.

Primary Hyperlipidemia and Mixed Dyslipidemia

Livazo 2mg tablets is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.

Limitations of Use

Doses of Livazo 2mg tablets greater than 4 mg once daily were associated with an increased risk for severe myopathy in premarketing clinical studies. Do not exceed 4 mg once daily dosing of Livazo 2mg tablets.

The effect of Livazo 2mg tablets on cardiovascular morbidity and mortality has not been determined.

Livazo 2mg tablets has not been studied in Fredrickson Type I, III, and V dyslipidemias.

How should I use Livazo 2mg?

Use Livazo 2mg as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Livazo 2mg.

Uses of Livazo 2mg in details

sponsored

Use: Labeled Indications

Primary hyperlipidemia and mixed dyslipidemia: As an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C) in adults with primary hyperlipidemia or mixed dyslipidemia.

Heterozygous familial hypercholesterolemia: As an adjunctive therapy to diet to reduce elevated total cholesterol, LDL-C, and apo B in children and adolescents ≥8 years of age.

Off Label Uses

Cardiac risk reduction for noncardiac surgery (perioperative therapy)

Based on the 2014 American College of Cardiology/American Heart Association (ACC/AHA) guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery, perioperative initiation of statins is reasonable for patients undergoing vascular surgery and may be considered in patients with clinical indications according to guideline-directed medical therapy who are undergoing elevated risk procedures. In patients undergoing non-cardiac surgery who are currently receiving a statin, the statin should be continued.

Noncardioembolic stroke/Transient ischemic attack (secondary prevention)

Based on the American Heart Association/American Stroke Association (AHA/ASA) guidelines for the prevention of stroke in patients with stroke and transient ischemic attack, statin therapy with intensive lipid-lowering effects is recommended to reduce the risk of recurrent stroke and future cardiovascular events in patients with ischemic stroke or TIA presumed to be of atherosclerotic origin who have an LDL-C concentration ≥100 mg/dL (with or without evidence for other clinical atherosclerotic cardiovascular disease [ASCVD]) or who have an LDL-C concentration <100 mg/dL (without evidence for other clinical ASCVD).

Primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD)

Based on the American College of Cardiology/American Heart Association (ACC/AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and the National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia, Livazo 2mg given for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) is effective and recommended in the management of this condition. Based on the US Preventive Services Task Force (USPSTF) recommendation statement on Statin Use for the Primary Prevention of Cardiovascular Disease (CVD) in Adults, initiation of low to moderate dose statin therapy is recommended in adults 40 to 75 years without a history of CVD who have ≥1 CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year CVD event risk of ≥10%. Based on the American Heart Association (AHA) scientific statement for the secondary prevention after coronary artery bypass graft surgery, statin therapy (unless contraindicated) is recommended for all coronary artery bypass graft (CABG) surgery patients to help maintain long-term graft patency and help obtain the highest level of physical health and quality of life.

Livazo 2mg description

sponsored

Livazo 2mg tablet contains the following excipients: Lactose, hydroxypropylcellulose, hydroxypropylmethylcellulose, magnesium aluminometasilicate, magnesium stearate, triethyl citrate, hydrated silicon dioxide, titanium oxide, carnauba wax.

Livazo 2mg calcium is (+)-monocalcium bis(3R,5S,6E)-7-[2-cyclopropyl- 4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate. It has a molecular formula of C50H46CaF2N2O8 and a molecular weight of 880.98.

It occurs as a white to pale yellowish white powder and is odorless. It is freely soluble in pyridine or in tetrahydrofuran, soluble in ethylene glycol, slightly soluble in methanol, very slightly soluble in ethanol (99.5) or in water, practically insoluble in acetonitrile or in diethyl ether. It dissolves in dilute hydrochloric acid.

Livazo 2mg dosage

Livazo 2mg Dosage

Generic name: Livazo 2mg calcium 1.045mg

Dosage form: tablet, film coated

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

General Dosing Information

The dose range for Livazo 2mg is 1 to 4 mg orally once daily at any time of the day with or without food. The recommended starting dose is 2 mg and the maximum dose is 4 mg. The starting dose and maintenance doses of Livazo 2mg should be individualized according to patient characteristics, such as goal of therapy and response.

After initiation or upon titration of Livazo 2mg, lipid levels should be analyzed after 4 weeks and the dosage adjusted accordingly.

Dosage in Patients with Renal Impairment

Patients with moderate and severe renal impairment (glomerular filtration rate 30 – 59 mL/min/1.73 m2 and 15 – 29 mL/min/1.73 m2 not receiving hemodialysis, respectively) as well as end-stage renal disease receiving hemodialysis should receive a starting dose of Livazo 2mg 1 mg once daily and a maximum dose of Livazo 2mg 2 mg once daily.

Use with Erythromycin

In patients taking erythromycin, a dose of Livazo 2mg 1 mg once daily should not be exceeded.

Use with Rifampin

In patients taking rifampin, a dose of Livazo 2mg 2 mg once daily should not be exceeded.

More about Livazo 2mg (Livazo 2mg)

Consumer resources

Professional resources

Related treatment guides

Livazo 2mg interactions

See also:
What other drugs will affect Livazo 2mg?

sponsored

Cyclosporine

Cyclosporine significantly increased Livazo 2mg exposure. Co-administration of cyclosporine with Livazo 2mg is contraindicated.

Erythromycin

Erythromycin significantly increased Livazo 2mg exposure. In patients taking erythromycin, a dose of Livazo 2mg 1 mg once daily should not be exceeded.

Rifampin

Rifampin significantly increased Livazo 2mg exposure. In patients taking rifampin, a dose of Livazo 2mg 2 mg once daily should not be exceeded.

Gemfibrozil

Due to an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are coadministered with gemfibrozil, concomitant administration of Livazo 2mg with gemfibrozil should be avoided.

Other Fibrates

Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates, Livazo 2mg should be administered with caution when used concomitantly with other fibrates.

Niacin

The risk of skeletal muscle effects may be enhanced when Livazo 2mg is used in combination with niacin; a reduction in Livazo 2mg dosage should be considered in this setting.

Colchicine

Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors coadministered with colchicine, and caution should be exercised when prescribing Livazo 2mg with colchicine.

Warfarin

Livazo 2mg had no significant pharmacokinetic interaction with R-and S-warfarin. Livazo 2mg had no significant effect on prothrombin time (PT) and international normalized ratio (INR) when administered to patients receiving chronic warfarin treatment. However, patients receiving warfarin should have their PT and INR monitored when Livazo 2mg is added to their therapy.

Livazo 2mg side effects

See also:
What are the possible side effects of Livazo 2mg?

Applies to Livazo 2mg: oral tablet

As well as its needed effects, Livazo 2mg (the active ingredient contained in Livazo 2mg) may cause unwanted side effects that require medical attention.

Major Side Effects

If any of the following side effects occur while taking Livazo 2mg, check with your doctor immediately:

Less common:

Incidence not known:

Minor Side Effects

Some Livazo 2mg side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Less common:

Incidence not known:

Livazo 2mg contraindications

See also:
What is the most important information I should know about Livazo 2mg?

You should not take Livazo 2mg if you are allergic to it, if you are pregnant or breast-feeding, or if you have liver disease or severe kidney disease. You should not take Livazo 2mg if you are also taking cyclosporine (Gengraf, Neoral, Sandimmune) or lopinavir and ritonavir (Kaletra).

Stop taking this medication and tell your doctor right away if you become pregnant.

Before taking Livazo 2mg, tell your doctor if you have a thyroid disorder, if you have ever had liver or kidney disease, or if you drink more than 2 alcoholic beverages daily.

In rare cases, Livazo 2mg can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine.

Avoid eating foods that are high in fat or cholesterol. Livazo 2mg will not be as effective in lowering your cholesterol if you do not follow a cholesterol-lowering diet plan.

Avoid drinking alcohol. It can raise triglyceride levels and may increase your risk of liver damage.

Livazo 2mg is only part of a complete program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.



Active ingredient matches for Livazo 2mg:

Pitavastatin in Switzerland.


List of Livazo 2mg substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
Pitava 1 mg x 1 Blister x 10 Tablet
PITAVA 1 MG TABLET 1 strip / 10 tablets each (Zydus Cadila)$ 1.08
PITAVA 2 MG TABLET 1 strip / 10 tablets each (Zydus Cadila)$ 1.86
Pitava 1mg Tablet (Zydus Cadila)$ 0.11
Pitava 2mg Tablet (Zydus Cadila)$ 0.19

References

  1. DailyMed. "PITAVASTATIN CALCIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "Pitavastatin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "Pitavastatin". http://www.drugbank.ca/drugs/DB08860 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Livazo 2mg are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Livazo 2mg. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 16 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved